Clinical Trials
3 trialsNCT01502085 2026-04-03
RZD
Hackensack Meridian Health
Phase 1/2 Completed
NCT01297764 2026-03-23
QUAD
Hackensack Meridian Health
Phase 1/2 Active not recruiting
NCT00857324 2017-09-06
Study of Vorinostat Plus Melphalan and Prednisone (Zmp) in Advanced, Refractory Multiple Myeloma Patients
University of Turin, Italy
Phase 1/2 Terminated